Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by FOSTER, H.
Right arrow Articles by GRIFFITHS, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FOSTER, H.
Right arrow Articles by GRIFFITHS, I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 British Society for Rheumatology


other

ASSOCIATION OF DR3 WITH SUSCEPTIBILITY TO AND SEVERITY OF PRIMARY SJÖGREN'SYNDROME IN A FAMILY STUDY

H. FOSTER, D. WALKER, P. CHARLES*, C. KELLY, G. CHAVANAGH{dagger} and I. GRIFFITHS

Department of Rheumatology, Royal Victoria Infirmary and Freeman Hospital Newcastle upon Tyne
*Immunology and Immunogenetics Laboratory, Department of Rheumatology, Charing Cross Hospital and Kennedy Institute of Rheumatology London
{dagger}Regional Blood Transfusion Service Barrack Road, Newcastle upon Tyne

Correspondence to: Correspondence to Dr Helen Foster, Department of Rheumatology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP

A study of HLA and primary Sjögren's syndrome (1°SS) was performed in 40 index cases and 180 relatives all of whom were Caucasian. The association of DR3 and 1°SS was confirmed. In probands, DR3 associated with extraglandular manifestations of 1°SS and homozygosity for DR3 associated with younger onset of disease. Familial clustering of 1°SS was evident. Definite or probable 1°SS (Fox criteria) occurred with a prevalence of 4.4% in the relatives, exclusively in older female first degree relatives and was associated with DR3. The relative risk was greatest in those who expressed antinuclear factor, rheumatoid factor or Ro and DR3. We identified a group of young females expressing some criteria for 1°SS and the same immunogenetic markers. They may be at risk of full expression of 1°SS as they become older. Milder forms of 1°SS were common in older relatives but not DR3 associated. 1°SS in males was rare and mild irrespective of immunogenetic status. Symptoms of 1°SS in relatives were mild or absent. Such individuals will only be identified through a family study or a community survey

KEY WORDS: Genetics, HLA, Ro and La antibodies


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.